Course info
Conferences and Meetings
Education Program
Education Program
Category: Conferences and Meetings
Short name: 2023 AM Invited Program + Oral Abstracts-Education Program
Course start date: 01/19/2026
Sections
General
0 activities
Education Program
0 activities
Acquired Hemophilia A Diagnosis and Management
4 activities
Alphabet Soup - Challenging Consults on the Pediatric Units
4 activities
Are We Personalizing MDS Therapy in 2023?
4 activities
CAR T Cells in ALL: Bridge or Definitive Therapy?
4 activities
Energizing the Red Cell: Pyruvate Kinase Activators for Treatment of Hereditary Hemolytic Anemias
4 activities
Goldilocks and Transplant Timing in Inherited Marrow Failure Syndromes: Too Early, Too Late, Just Right?
4 activities
Graft Versus Host Disease: Is an Ounce of Prevention Worth a Pound of Cure?
4 activities
Have We Optimized Therapy Yet for Patients with AML?
3 activities
Hematologic Toxicity of Immunotherapies
4 activities
Hematologists and the Care of Pregnant Women
4 activities
Hematologists as Lifesavers: Inpatient Hematology Emergencies
4 activities
Hemostasis in Patients With Severe Liver Disease
4 activities
Hot Topics in Blood Donation: Donor Risks and Social Justice
4 activities
How Can We Manage High-Risk Hematologic Malignancies in the Community?
4 activities
How Do We Apply T-Cell Redirection Therapy for Multiple Myeloma? CAR T-Cells and Bispecific Antibodies
4 activities
How Do We Calibrate Cellular Therapy for Lymphoma in 2023?
4 activities
How Do We Enhance Results in Rare Hematologic Malignancies?
4 activities
How Do We Extend Survival for Patients with Chronic Lymphocytic Leukemia (CLL) in 2023?
4 activities
How Do We Improve Outcomes in Relapsed and Refractory Multiple Myeloma in 2023?
5 activities
How Do We Tackle Remaining Clinical Challenges in CML?
4 activities
How is the Management Paradigm Evolving for Hodgkin Lymphoma in 2023?
4 activities
Improving Outcomes for Individuals With Sickle Cell Disease: Are We Moving the Needle?
5 activities
Inherited Bone Marrow Failure Syndromes - From Pediatrics to Adult
4 activities
Not Kids Anymore and Not Adults Yet: How Do We Treat Adolescent and Young Adult (AYA) Patients With ALL?
4 activities
Ongoing Challenges in the Management of VTE
5 activities
The Iron Revolution!
4 activities
Transfusion Support in Sickle Cell Disease
4 activities
What Are the Advances in Myeloproliferative Neoplasms Affecting Management?
4 activities
What Makes a Good Transplant Recipient? Putting the Puzzle Pieces Together
4 activities
What are Treatment Options for Patients with Relapsed, Refractory or Persistent AML?
5 activities
Why Am I Getting Paged at 2AM? Microangiopathic Emergencies
4 activities
31
96